Medical University of South Carolina
Gynecologic Oncology fellowship · Charleston, SC · Medical University of South Carolina programs · Program website
Obstetrics and Gynecology residency here · Other fellowships: Maternal-Fetal Medicine
Fellows here publish most often with Taylor J. Orellana, Paramita Chakraborty, and Shikhar Mehrotra at Medical University of South Carolina. How fellows publish ↓
- 3
- Fellows
- 67%
- Have published here
- 0.47
- Papers per fellow-year
- 0%
- Papers led by a fellow
- 100%
- With a co-author at Medical University of South Carolina
Roster from the program's own pages 1 · 2, collected 2026-11-08: 3 current fellows in 3 classes. Something off? Tell us
Papers
By this program's leadership and fellows since 2022, 84 in all · 2 with a fellow author. Updated 2026-11-09.
- Cytokine Programming Combined with 4-1BB Enrichment Enhances Ovarian TIL Expansion and Function 2260346Paramita Chakraborty et al. · The Journal of Immunology · 2026
- It's not just a number: Age at diagnosis varies by molecular subtype in endometrial cancerSydney Oesch et al. · Gynecologic Oncology · 2026
Trainees aren't named, for privacy. A paper is included when one of its authors is a current resident or fellow, or a graduate of the last two years, and it came out during their training.
How fellows publishauthor positions, co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 2 of 3 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Justin Harold, M.D.APD | Endometrial and Cervical Cancer Treatments; PARP inhibition in cancer therapy | 16 | 34 | 5 | 2 | 0.78 |
| Whitney S. Graybill, M.D., MS | PARP inhibition in cancer therapy; Ovarian cancer diagnosis and treatment | 20 | 34 | 3 | 0 | 0.53 |
| Brian Orr, M.D. | Ovarian cancer diagnosis and treatment; Endometrial and Cervical Cancer Treatments | 13 | 24 | 1 | 4 | 0.33 |
3 trainees are counted above but never listed by name.
Gynecologic Oncology at Medical University of South Carolinashared by every program there, not this program's own
Institution-level: all gynecologic oncology publications from Medical University of South Carolina and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Gynecologic Oncology research topics at Medical University of South Carolina
Papers in the window; each links to the list on OpenAlex.
Most cited at Medical University of South Carolina since 2024
All gynecologic oncology papers there on OpenAlex
- Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa et al. · Cancer Cell · 2025 · PubMed · cited 42
- Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R. Cottrell et al. · Journal for ImmunoTherapy of Cancer · 2025 · PubMed · cited 63
- Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple MyelomaDoris K. Hansen et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 62
- Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trialBradley J. Monk et al. · Annals of Oncology · 2024 · PubMed · cited 203
- Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson et al. · Transplantation and Cellular Therapy · 2024 · PubMed · cited 44
- Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialAlexander Gerhard Miethke et al. · The Lancet. Gastroenterology & hepatology · 2024 · PubMed · cited 83
- 3D genomic mapping reveals multifocality of human pancreatic precancersAlicia M. Braxton et al. · Nature · 2024 · PubMed · cited 165
- National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health CentersTrisha L. Amboree et al. · JAMA Internal Medicine · 2024 · PubMed · cited 53
- Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple MyelomaNico Gagelmann et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 96
- Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast CancerMustafa Emre Gedik et al. · Cancer Research · 2024 · PubMed · cited 42
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/medical-university-south-carolina-gyn-onc"><img src="https://openprograms.org/programs/medical-university-south-carolina-gyn-onc/badge.svg" alt="Medical University of South Carolina Gynecologic Oncology fellowship on OpenPrograms" height="20"></a><iframe src="https://openprograms.org/embed/medical-university-south-carolina-gyn-onc" title="Recent papers, Medical University of South Carolina Gynecologic Oncology fellowship" width="100%" height="520" style="border:0" loading="lazy"></iframe>Something wrong or missing on this page? Use the correction form below; changes show up in both.